Danaher Corporation

DHR

NYSE

USReal-Time Price

$232.44USD

-2.50 (-1.06%)Today

BTI Score

BASIC required or higher

View pricing

BTI Fair Market Cap

$83.22B

+96.50% vs fair

Healthcare & Pharma

Hold

Danaher Corporation (DHR) Valuation

Is Danaher Corporation (DHR) overvalued or undervalued? BTI's fair-value estimate, DCF model and valuation multiples show the premium or discount to intrinsic worth.

Valuation Snapshot

P/E (TTM)

Trailing Price-to-Earnings

38.00

Forward P/E

Next 12 months estimate

25.27

PEG Ratio

P/E to Growth ratio

—

Price / Sales

Market cap vs. revenue

—

Price / Book

Market cap vs. book value

—

EV / EBITDA

Enterprise value multiple

—

Earnings Yield

Inverse of P/E

2.63%

Revenue Growth

Year-over-year

—

Valuation Risk

Danaher Corporation's valuation multiples are within a moderate range, suggesting the market is not pricing in excessive optimism. Investors should monitor growth execution relative to valuation.

Run Full Valuation Model

DCF, multiples, scenario analysis and AI fair value for DHR